These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34634770)

  • 41. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris.
    Bakos L; Brito AC; Castro LC; Gontijo B; Lowy G; Reis CM; Ribeiro AM; Souza FH; Villar Mdo L; Zaitz C
    Pediatr Infect Dis J; 1997 Jun; 16(6):545-8. PubMed ID: 9194102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris.
    Pariser DM; Pariser RJ; Ruoff G; Ray TL
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):232-4. PubMed ID: 8040406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of tinea corporis or tinea cruris with bifonazole 1% gel: an open, multicentre study.
    Belli L; Galimberti R; Negroni R; Rohwedder R; Castro JM
    Pharmatherapeutica; 1985; 4(2):106-8. PubMed ID: 4059289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
    Faergemann J; Mörk NJ; Haglund A; Odegård T
    Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
    J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal resistance in dermatophytes: Recent trends and therapeutic implications.
    Khurana A; Sardana K; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103255. PubMed ID: 31330295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages.
    Degreef H; Mariën K; De Veylder H; Duprez K; Borghys A; Verhoeve L
    Rev Infect Dis; 1987; 9 Suppl 1():S104-8. PubMed ID: 3027832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of DermaGenius
    Singh A; Singh P; Dingemans G; Meis JF; Chowdhary A
    Mycoses; 2021 Jul; 64(7):721-726. PubMed ID: 33760310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
    Jegasothy BV; Pakes GE
    Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis.
    Das A; Sil A; Sarkar TK; Sen A; Chakravorty S; Sengupta M; Das A; Chandra S; Pal S; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2019; 85(3):276-281. PubMed ID: 30409926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin - A prospective, randomized comparative study.
    Bhatia A; Kanish B; Badyal DK; Kate P; Choudhary S
    Indian J Pharmacol; 2019; 51(2):116-119. PubMed ID: 31142947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microsporum canis infection in three familial cases with tinea capitis and tinea corporis.
    Yin B; Xiao Y; Ran Y; Kang D; Dai Y; Lama J
    Mycopathologia; 2013 Oct; 176(3-4):259-65. PubMed ID: 23918090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris.
    Jones TM; Jarratt MT; Mendez-Moguel I; Paz N; Grekin SK; Cognata Smith C; Kaur M
    J Drugs Dermatol; 2014 Jan; 13(1):32-8. PubMed ID: 24385117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
    del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
    Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Clinico-mycological, Antifungal Drug Sensitivity and Therapeutic Study of Extensive Dermatophytosis in Coastal Andhra Pradesh.
    Vanapalli S; Turpati NR; Gopal KVT; Krishnam Raju PV; Devi BG
    Indian Dermatol Online J; 2022; 13(6):747-753. PubMed ID: 36386757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tinea corporis, tinea cruris, tinea nigra, and piedra.
    Gupta AK; Chaudhry M; Elewski B
    Dermatol Clin; 2003 Jul; 21(3):395-400, v. PubMed ID: 12956194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicomycological Profile and Risk Factors for Dermatophytosis at a Teaching Tertiary Care Centre in North India: A Cross-sectional Study.
    Singla P; Garg S; Singh P; Sharma N; Mane P; Singh NK; Sharma S
    Infect Disord Drug Targets; 2023; 23(6):e280423216334. PubMed ID: 37132314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.